Corteva, Inc. (CTVA) stock
CTVANYSEAgricultural Production-CropsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 18/3081% below fair value
$9.19−2.95 (-24.30%)
Close on Nov 12, 2026Market cap $6.13BP/E 8.1Yield 7.62%
Corteva EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Corteva's EPS for the twelve months ending Sep 30, 2026 was $1.13, down 51.7% year over year. For fiscal 2025 it was $1.60, up 23.1% from the year before. The highest annual figure on record is $2.37 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60 | +23.1% |
| FY2024 | Dec 31, 2024 | $1.30 | +26.2% |
| FY2023 | Dec 31, 2023 | $1.03 | -34.8% |
| FY2022 | Dec 31, 2022 | $1.58 | -33.3% |
| FY2021 | Dec 31, 2021 | $2.37 | +160.4% |
| FY2020 | Dec 31, 2020 | $0.91 | – |
| FY2019 | Dec 31, 2019 | -$1.28 | – |
| FY2018 | Dec 31, 2018 | -$6.76 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.85 | – |
| Q2 FY2026 | Jun 30, 2026 | $1.73 | -9.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.07 | +12.6% |
| Q4 FY2025 | Dec 31, 2025 | -$0.82 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.47 | – |
| Q2 FY2025 | Jun 30, 2025 | $1.92 | +27.2% |
| Q1 FY2025 | Mar 31, 2025 | $0.95 | +58.3% |
| Q4 FY2024 | Dec 31, 2024 | -$0.06 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.76 | – |
| Q2 FY2024 | Jun 30, 2024 | $1.51 | +51.0% |
| Q1 FY2024 | Mar 31, 2024 | $0.60 | -27.7% |
| Q4 FY2023 | Dec 31, 2023 | -$0.36 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.45 | – |
| Q2 FY2023 | Jun 30, 2023 | $1.00 | -24.8% |
| Q1 FY2023 | Mar 31, 2023 | $0.83 | +6.4% |
| Q4 FY2022 | Dec 31, 2022 | -$0.08 | -300.0% |
| Q3 FY2022 | Sep 30, 2022 | -$0.46 | -135.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.33 | +66.3% |
| Q1 FY2022 | Mar 31, 2022 | $0.78 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.04 | – |
| Q2 FY2021 | Jun 30, 2021 | $1.31 | +29.7% |
| Q1 FY2021 | Mar 31, 2021 | $0.80 | +122.2% |
| Q4 FY2020 | Dec 31, 2020 | $0.00 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.52 | – |
| Q2 FY2020 | Jun 30, 2020 | $1.01 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.36 | +63.6% |
| Q4 FY2019 | Dec 31, 2019 | $0.00 | – |
| Q3 FY2019 | Sep 30, 2019 | -$0.66 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.81 | -188.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.22 | – |
| Q4 FY2018 | Dec 31, 2018 | $0.00 | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.83 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.92 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?